367 related articles for article (PubMed ID: 28418656)
1. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
[TBL] [Abstract][Full Text] [Related]
2. Toward in silico structure-based ADMET prediction in drug discovery.
Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
[TBL] [Abstract][Full Text] [Related]
3. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
Khan MT; Sylte I
Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
[TBL] [Abstract][Full Text] [Related]
4. Modeling ADMET.
Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
[TBL] [Abstract][Full Text] [Related]
5. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
Tsaioun K; Jacewicz M
Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
[TBL] [Abstract][Full Text] [Related]
6. Recent uses of topological indices in the development of in silico ADMET models.
Votano JR
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
[TBL] [Abstract][Full Text] [Related]
7. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
van de Waterbeemd H
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
[TBL] [Abstract][Full Text] [Related]
8. In silico ADME-Tox modeling: progress and prospects.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
[TBL] [Abstract][Full Text] [Related]
9. Modern drug discovery technologies: opportunities and challenges in lead discovery.
Guido RV; Oliva G; Andricopulo AD
Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147
[TBL] [Abstract][Full Text] [Related]
10. ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd H; Gifford E
Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
[TBL] [Abstract][Full Text] [Related]
11. In silico prediction of cytochrome P450-mediated drug metabolism.
Zhang T; Chen Q; Li L; Liu LA; Wei DQ
Comb Chem High Throughput Screen; 2011 Jun; 14(5):388-95. PubMed ID: 21470181
[TBL] [Abstract][Full Text] [Related]
12. Improving compound quality through in vitro and in silico physicochemical profiling.
van de Waterbeemd H
Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
[TBL] [Abstract][Full Text] [Related]
13. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
Duffy BC; Zhu L; Decornez H; Kitchen DB
Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
[TBL] [Abstract][Full Text] [Related]
14. Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes.
Sutherland JJ; Raymond JW; Stevens JL; Baker TK; Watson DE
J Med Chem; 2012 Jul; 55(14):6455-66. PubMed ID: 22716080
[TBL] [Abstract][Full Text] [Related]
15. The application of in silico drug-likeness predictions in pharmaceutical research.
Tian S; Wang J; Li Y; Li D; Xu L; Hou T
Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
[TBL] [Abstract][Full Text] [Related]
16. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
17. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
18. Biophysics: for HTS hit validation, chemical lead optimization, and beyond.
Genick CC; Wright SK
Expert Opin Drug Discov; 2017 Sep; 12(9):897-907. PubMed ID: 28658992
[TBL] [Abstract][Full Text] [Related]
19. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
Martin E; Mukherjee P; Sullivan D; Jansen J
J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
[TBL] [Abstract][Full Text] [Related]
20. In silico pharmacology for a multidisciplinary drug discovery process.
Ortega SS; Cara LC; Salvador MK
Drug Metabol Drug Interact; 2012; 27(4):199-207. PubMed ID: 23152402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
